Medline Inc. (MDLN)

Medline Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	1,157	1,200	234	-25
Depreciation & Amortization	1,011	977	951	933
Stock-Based Compensation	76	61	78	64
Other Adjustments	283	206	223	134
Change in Receivables	-355	-256	-153	-376
Changes in Inventories	-264	-545	444	-195
Changes in Accounts Payable	73	106	136	-103
Changes in Accrued Expenses	-92	62	-112	-144
Changes in Other Operating Activities	-145	-42	-116	-101
Operating Cash Flow	1,744	1,769	1,685	187
Operating Cash Flow Growth	-1.41%	4.98%	801.07%	-
Capital Expenditures	-447	-354	-275	-254
Proceeds from Sale of Investments	-	-	-	7
Payments for Business Acquisitions	-27	-1,136	-26	-17
Other Investing Activities	-	-3	-11	-
Investing Cash Flow	-474	-1,493	-312	-264
Short-Term Debt Issued	179	166	-	80
Short-Term Debt Repaid	-179	-166	-	-80
Long-Term Debt Issued	7,569	15,932	-	-
Long-Term Debt Repaid	-11,661	-15,995	-77	-61
Net Long-Term Debt Issued (Repaid)	-4,092	-63	-77	-61
Issuance of Common Stock	7,048	-	-	-
Repurchase of Common Stock	-2,003	-20	-	-
Net Common Stock Issued (Repurchased)	5,045	-20	-	-
Common Dividends Paid	-518	-1,518	-114	-23
Other Financing Activities	-36	-12	-	-
Financing Cash Flow	399	-1,613	-191	-84
Effect of Exchange Rate Changes on Cash and Cash Equivalents	23	2	4	-30
Net Cash Flow	1,692	-1,335	1,186	-191
Free Cash Flow	1,297	1,415	1,410	-67
Free Cash Flow Growth	-8.34%	0.36%	-	-
FCF Margin	4.56%	5.55%	6.07%	-0.31%
Free Cash Flow Per Share	1.60	-	-	-
Levered Free Cash Flow	-2,797	1,341	1,185	50
Unlevered Free Cash Flow	2,187	2,271	2,136	-2,017

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q